Methotrexate for ocular inflammatory diseases.

  title={Methotrexate for ocular inflammatory diseases.},
  author={Sapna S. Gangaputra and Craig W. Newcomb and Teresa L. Liesegang and Roje O. Kacmaz and Douglas A. Jabs and Grace A. Levy-Clarke and Robert B. Nussenblatt and James T. Rosenbaum and Eric B. Suhler and Jennifer E. Thorne and Charles Stephen Foster and John H Kempen},
  volume={116 11},
PURPOSE To evaluate the outcome of treatment with methotrexate for noninfectious ocular inflammation. DESIGN Retrospective cohort study. PARTICIPANTS Patients with noninfectious ocular inflammation managed at 4 tertiary ocular inflammation clinics in the United States observed to add methotrexate as a single, noncorticosteroid immunosuppressive agent to their treatment regimen, between 1979 and 2007, inclusive. METHODS Participants were identified from the Systemic Immunosuppressive… CONTINUE READING
64 Citations
49 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 64 extracted citations


Publications referenced by this paper.
Showing 1-10 of 49 references

Adrenocorticotropic hormone; adrenocortical steroids and their synthetic analogs; inhibitors of the synthesis and actions of adrenocortical hormones

  • BP Schimmer, KL Parker
  • Brunton LL, ed; Lazo JS, Parker KL, assoc eds…
  • 2006

Similar Papers

Loading similar papers…